Marshall Wace’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Marshall Wace’s Portfolio RACB Stock Details RACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-593,542	Closed	-$5.83M	–	3800
2022 Q3	$5.83M	Buy	593,542 +247,608	+72%	+$2.43M	0.01%	1261
2022 Q2	$3.39M	Hold	345,934	–	–	0.01%	1639
2022 Q1	$3.38M	Buy	345,934 +17,234	+5%	+$168K	0.01%	1705
2021 Q4	$3.2M	Buy	328,700 +100,000	+44%	+$984K	0.01%	1719
2021 Q3	$2.25M	Hold	228,700	–	–	0.01%	1462
2021 Q2	$2.29M	Hold	228,700	–	–	0.01%	1335
2021 Q1	$2.34M	Buy	+228,700	New	+$2.34M	0.01%	1246

Marshall Wace's RACB Position: Q4 2022 in Review

Marshall Wace sold out of Research Alliance Corp. II Class A Common Stock (RACB) in Q4 2022, closing a stake of 593,542 shares — an estimated $5.83M sold.

Marshall Wace first reported a position in RACB in Q1 2021 and held it in 7 quarters. The position peaked at $5.83M in Q3 2022. 0 funds tracked by Wall St. Rank hold RACB as of Q4 2022.

Marshall Wace reported no remaining Research Alliance Corp. II Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 593,542 Research Alliance Corp. II Class A Common Stock shares in Q4 2022, an estimated $5.83M.
Marshall Wace first reported a position in Research Alliance Corp. II Class A Common Stock in Q1 2021 and held it in 7 quarters.
Marshall Wace's Research Alliance Corp. II Class A Common Stock position peaked at $5.83M in Q3 2022.
0 funds tracked by Wall St. Rank held Research Alliance Corp. II Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.